| Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma AM Fontebasso, S Papillon-Cavanagh, J Schwartzentruber, H Nikbakht, ... Nature genetics 46 (5), 462-466, 2014 | 444 | 2014 |
| The histone mark H3K36me2 recruits DNMT3A and shapes the intergenic DNA methylation landscape DN Weinberg, S Papillon-Cavanagh, H Chen, Y Yue, X Chen, ... Nature 573 (7773), 281-286, 2019 | 412 | 2019 |
| Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscape C Lu, SU Jain, D Hoelper, D Bechet, RC Molden, L Ran, D Murphy, ... Science 352 (6287), 844-849, 2016 | 381 | 2016 |
| H3K27M induces defective chromatin spread of PRC2-mediated repressive H3K27me2/me3 and is essential for glioma tumorigenesis AS Harutyunyan, B Krug, H Chen, S Papillon-Cavanagh, M Zeinieh, ... Nature communications 10 (1), 1262, 2019 | 273 | 2019 |
| mRMRe: an R package for parallelized mRMR ensemble feature selection N De Jay, S Papillon-Cavanagh, C Olsen, N El-Hachem, G Bontempi, ... Bioinformatics 29 (18), 2365-2368, 2013 | 259 | 2013 |
| Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma H Nikbakht, E Panditharatna, LG Mikael, R Li, T Gayden, M Osmond, ... Nature communications 7 (1), 11185, 2016 | 240 | 2016 |
| Impaired H3K36 methylation defines a subset of head and neck squamous cell carcinomas S Papillon-Cavanagh, C Lu, T Gayden, LG Mikael, D Bechet, ... Nature genetics 49 (2), 180-185, 2017 | 235 | 2017 |
| Fusion of TTYH1 with the C19MC microRNA cluster drives expression of a brain-specific DNMT3B isoform in the embryonal brain tumor ETMR CL Kleinman, N Gerges, S Papillon-Cavanagh, P Sin-Chan, ... Nature genetics 46 (1), 39-44, 2014 | 214 | 2014 |
| STK11 and KEAP1 mutations as prognostic biomarkers in an observational real-world lung adenocarcinoma cohort S Papillon-Cavanagh, P Doshi, R Dobrin, J Szustakowski, AM Walsh ESMO open 5 (2), e000706, 2020 | 170 | 2020 |
| Mutations in C5ORF42 cause Joubert syndrome in the French Canadian population M Srour, J Schwartzentruber, FF Hamdan, LH Ospina, L Patry, D Labuda, ... The American Journal of Human Genetics 90 (4), 693-700, 2012 | 143 | 2012 |
| Spatial heterogeneity in medulloblastoma AS Morrissy, FMG Cavalli, M Remke, V Ramaswamy, DJH Shih, ... Nature genetics 49 (5), 780-788, 2017 | 141 | 2017 |
| The molecular landscape of ETMR at diagnosis and relapse S Lambo, SN Gröbner, T Rausch, SM Waszak, C Schmidt, A Gorthi, ... Nature 576 (7786), 274-280, 2019 | 120 | 2019 |
| Mutation in The Nuclear‐Encoded Mitochondrial Isoleucyl–tRNA Synthetase IARS2 in Patients with Cataracts, Growth Hormone Deficiency with Short Stature … J Schwartzentruber, D Buhas, J Majewski, F Sasarman, ... Human mutation 35 (11), 1285-1289, 2014 | 94 | 2014 |
| Comparison and validation of genomic predictors for anticancer drug sensitivity S Papillon-Cavanagh, N De Jay, N Hachem, C Olsen, G Bontempi, ... Journal of the American Medical Informatics Association 20 (4), 597-602, 2013 | 82 | 2013 |
| Biomarker analysis from CheckMate 214: nivolumab plus ipilimumab versus sunitinib in renal cell carcinoma RJ Motzer, TK Choueiri, DF McDermott, T Powles, YA Vano, S Gupta, ... Journal for ImmunoTherapy of Cancer 10 (3), 2022 | 64 | 2022 |
| Mutations in a novel serine protease PRSS56 in families with nanophthalmos A Orr, MP Dubé, JC Zenteno, H Jiang, G Asselin, SC Evans, A Caqueret, ... Molecular vision 17, 1850, 2011 | 58 | 2011 |
| Epigenetic dysregulation: a novel pathway of oncogenesis in pediatric brain tumors AM Fontebasso, T Gayden, H Nikbakht, M Neirinck, S Papillon-Cavanagh, ... Acta neuropathologica 128, 615-627, 2014 | 47 | 2014 |
| Biomarker analyses from the phase III CheckMate 214 trial of nivolumab plus ipilimumab (N+ I) or sunitinib (S) in advanced renal cell carcinoma (aRCC). RJ Motzer, TK Choueiri, DF McDermott, T Powles, J Yao, R Ammar, ... Journal of Clinical Oncology 38 (15_suppl), 5009-5009, 2020 | 43 | 2020 |
| Molecular correlates of response to nivolumab at baseline and on treatment in patients with RCC P Ross-Macdonald, AM Walsh, SD Chasalow, R Ammar, ... Journal for immunotherapy of cancer 9 (3), 2021 | 28 | 2021 |
| A multi‐omic single cell sequencing approach to develop a CD8 T cell specific gene signature for anti‐PD1 response in solid tumors N Kumar, S Papillon‐Cavanagh, H Tang, S Wang, C Stromko, CP Ho, ... International journal of cancer 151 (11), 2043-2054, 2022 | 4 | 2022 |
